Related Experiment Video
Updated: Jan 16, 2026
07:46
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
25.9K
Obesity, diabetes, and inflammation: Pathophysiology and clinical implications
Marc Y Donath1, Daniel J Drucker2
1Integrated Centre of Excellence in Metabolic Health and Endocrine Division, Department of Medicine and Centre de Recherche, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.
Immunity
|October 4, 2025
Summary
Obesity causes chronic inflammation, leading to metabolic diseases. Glucagon-like peptide-1 (GLP-1) receptor agonists show anti-inflammatory effects, offering new therapeutic avenues for these conditions.
Area of Science:
- Immunology
- Metabolic Diseases
- Pharmacology
Background:
- Obesity and related disorders (type 2 diabetes, cardiovascular, liver, kidney diseases) are chronic inflammatory conditions.
- Nutrient excess activates immune pathways like pattern recognition receptors and the NLRP3 inflammasome, producing IL-1β and cytokines.
- Chronic inflammation contributes to insulin resistance, beta-cell dysfunction, and end-organ damage.
Purpose of the Study:
- To review the mechanisms of inflammation in obesity-related disorders.
- To discuss the anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) receptor agonists.
- To explore therapeutic potential for chronic inflammatory diseases.
Main Methods:
- Review of existing literature on inflammation in metabolic diseases.
- Analysis of immune activation pathways triggered by nutrient excess.
- Examination of GLP-1 receptor agonist mechanisms and effects.
Main Results:
- Nutrient excess triggers immune activation, initially adaptive but chronically damaging.
- GLP-1 receptor agonists demonstrate significant anti-inflammatory effects.
- These effects can be independent of glucose control or weight loss, mediated by direct GLP-1R signaling and CNS pathways.
Conclusions:
- Understanding inflammation mechanisms in obesity is crucial for disease management.
- GLP-1 receptor agonists offer promising therapeutic strategies due to their anti-inflammatory properties.
- Targeting GLP-1R signaling may unlock new treatments for chronic inflammatory diseases.
Related Concept Videos
01:24Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
01:20Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
01:19Psychoneuroimmunology: Diabetes and Cancer
449
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
449
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
01:36Carbohydrate Metabolism
13.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.8K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
246
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
246